Should we stop prescribing pioglitazone?
نویسندگان
چکیده
منابع مشابه
Should we stop prescribing metoclopramide as a prokinetic drug in critically ill patients?
Regulatory agencies in North America and Europe recently re-evaluated the safety of metoclopramide. This re-evaluation resulted in recommendations and restrictions in order to minimise the risk of neurological and other adverse reactions associated with the use of metoclopramide. In the ICU, off-label prescription of metoclopramide is common. We have reviewed the evidence for safety, effectiven...
متن کاملEditorial Atherosclerosis Should We Stop TWEAKing It ?
Atherosclerosis is a very complex pathology. Over the past two decades we have come to appreciate that a major component of this pathological process is chronic inflammation. This inflammatory state is not only characterized by infiltration of lipid laden macrophages, the hallmark cell of this disease, into the vascular wall, but also is characterized by the infiltration of a host of other infl...
متن کاملAtherosclerosis: should we stop TWEAKing it?
Atherosclerosis is a very complex pathology. Over the past two decades we have come to appreciate that a major component of this pathological process is chronic inflammation. This inflammatory state is not only characterized by infiltration of lipid laden macrophages, the hallmark cell of this disease, into the vascular wall, but also is characterized by the infiltration of a host of other infl...
متن کاملWhy We Should Stop Creating Pets with Lives Worth Living
Pedigreed breeding often leads to severe health problems for, say, those dogs who exist as a result of the practice. It is also the case that virtually all of those unhealthy animals would not exist at all if it were not for the practice of pedigreed breeding. If those animals have lives worth living, then it follows that they are not harmed by the practice—assuming that a life worth living is ...
متن کاملShould we stop telling obese patients to lose weight?
Is the treatment of obesity futile? This is the question being asked on the following pages. Havrankova2 claims that it is (page 508), whereas Garrel3 claims the opposite (page 509). No matter what their respective opinions, the simple fact that we, as family doctors, are asking ourselves this question suggests we are uneasy when trying to help our obese patients. In fact, many of us believe th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Clinical Pharmacology
سال: 2014
ISSN: 0306-5251
DOI: 10.1111/bcp.12342